184 related articles for article (PubMed ID: 22642547)
1. Specific detection of integrin αvβ3 by light-up bioprobe with aggregation-induced emission characteristics.
Shi H; Liu J; Geng J; Tang BZ; Liu B
J Am Chem Soc; 2012 Jun; 134(23):9569-72. PubMed ID: 22642547
[TBL] [Abstract][Full Text] [Related]
2. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
Arosio D; Manzoni L; Araldi EM; Caprini A; Monferini E; Scolastico C
Bioconjug Chem; 2009 Aug; 20(8):1611-7. PubMed ID: 21141806
[TBL] [Abstract][Full Text] [Related]
3. A photostable fluorescent probe for targeted imaging of tumour cells possessing integrin alpha(v)beta(3).
Xiong L; Yu M; Cheng M; Zhang M; Zhang X; Xu C; Li F
Mol Biosyst; 2009 Mar; 5(3):241-3. PubMed ID: 19225614
[TBL] [Abstract][Full Text] [Related]
4. αvβ3-Integrin-targeting lanthanide complex: synthesis and evaluation as a tumor-homing luminescent probe.
Ito T; Inoue M; Akamatsu K; Kusaka E; Tanabe K; Nishimoto S
Bioorg Med Chem Lett; 2011 Jun; 21(12):3515-8. PubMed ID: 21600766
[TBL] [Abstract][Full Text] [Related]
5. Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding.
Kubas H; Schäfer M; Bauder-Wüst U; Eder M; Oltmanns D; Haberkorn U; Mier W; Eisenhut M
Nucl Med Biol; 2010 Nov; 37(8):885-91. PubMed ID: 21055618
[TBL] [Abstract][Full Text] [Related]
6. High expression of integrin αvβ3 enables uptake of targeted fluorescent probes into ovarian cancer cells and tumors.
Shaw SK; Schreiber CL; Roland FM; Battles PM; Brennan SP; Padanilam SJ; Smith BD
Bioorg Med Chem; 2018 May; 26(8):2085-2091. PubMed ID: 29548784
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome.
Waldeck J; Häger F; Höltke C; Lanckohr C; von Wallbrunn A; Torsello G; Heindel W; Theilmeier G; Schäfers M; Bremer C
J Nucl Med; 2008 Nov; 49(11):1845-51. PubMed ID: 18927332
[TBL] [Abstract][Full Text] [Related]
8. A new optical imaging probe targeting αVβ3 integrin in glioblastoma xenografts.
Lanzardo S; Conti L; Brioschi C; Bartolomeo MP; Arosio D; Belvisi L; Manzoni L; Maiocchi A; Maisano F; Forni G
Contrast Media Mol Imaging; 2011; 6(6):449-58. PubMed ID: 22144022
[TBL] [Abstract][Full Text] [Related]
9. Light-up bioprobe with aggregation-induced emission characteristics for real-time apoptosis imaging in target cancer cells.
Ding D; Liang J; Shi H; Kwok RTK; Gao M; Feng G; Yuan Y; Tang BZ; Liu B
J Mater Chem B; 2014 Jan; 2(2):231-238. PubMed ID: 32261611
[TBL] [Abstract][Full Text] [Related]
10. Peptide-induced aggregation of glutathione-capped gold nanoclusters: A new strategy for designing aggregation-induced enhanced emission probes.
You JG; Tseng WL
Anal Chim Acta; 2019 Oct; 1078():101-111. PubMed ID: 31358207
[TBL] [Abstract][Full Text] [Related]
11. Bioprobes based on AIE fluorogens.
Ding D; Li K; Liu B; Tang BZ
Acc Chem Res; 2013 Nov; 46(11):2441-53. PubMed ID: 23742638
[TBL] [Abstract][Full Text] [Related]
12. Real-time near infrared fluorescence (NIRF) intra-operative imaging in ovarian cancer using an α(v)β(3-)integrin targeted agent.
Harlaar NJ; Kelder W; Sarantopoulos A; Bart J; Themelis G; van Dam GM; Ntziachristos V
Gynecol Oncol; 2013 Mar; 128(3):590-5. PubMed ID: 23262209
[TBL] [Abstract][Full Text] [Related]
13. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
[TBL] [Abstract][Full Text] [Related]
14. Capillary electrophoresis frontal analysis for characterization of alphavbeta3 integrin binding interactions.
Sun Y; Cressman S; Fang N; Cullis PR; Chen DD
Anal Chem; 2008 May; 80(9):3105-11. PubMed ID: 18366190
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner.
Vellon L; Menendez JA; Liu H; Lupu R
Differentiation; 2007 Nov; 75(9):819-30. PubMed ID: 17999741
[TBL] [Abstract][Full Text] [Related]
16. Binding investigation of integrin alphavbeta3 with its inhibitors by SPR technology and molecular docking simulation.
Liu Y; Pan Y; Xu Y
J Biomol Screen; 2010 Feb; 15(2):131-7. PubMed ID: 20086207
[TBL] [Abstract][Full Text] [Related]
17. Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ.
Yuan Y; Kwok RT; Tang BZ; Liu B
J Am Chem Soc; 2014 Feb; 136(6):2546-54. PubMed ID: 24437551
[TBL] [Abstract][Full Text] [Related]
18. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors.
Xiong L; Chen Z; Tian Q; Cao T; Xu C; Li F
Anal Chem; 2009 Nov; 81(21):8687-94. PubMed ID: 19817386
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
McQuade P; Knight LC; Welch MJ
Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
[TBL] [Abstract][Full Text] [Related]
20. Rational design of fluorescent light-up probes based on an AIE luminogen for targeted intracellular thiol imaging.
Yuan Y; Kwok RT; Feng G; Liang J; Geng J; Tang BZ; Liu B
Chem Commun (Camb); 2014 Jan; 50(3):295-7. PubMed ID: 24244944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
